House Passes $900B+ National Defense Authorization Act for 2026, Boosting Military Pay and Curbing Chinese Tech
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
This bill passed the House of Representatives in September 2025 and is now waiting for the Senate to take action. The bill is stalled because no progress has been made in the Senate since September 2025. It is common for bills that pass the House to never receive a vote in the Senate.
231–196
No action since September 2025
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
The bill contains several provisions that directly and negatively affect LGBTQ service members and their families. It prohibits TRICARE coverage for gender-related medical treatment, bans men from participating in women's sports at Service Academies, prohibits single-sex facilities on military installations that don't correspond to biological sex, and bars gender identity questions in DOD surveys and forms. It also prohibits the Exceptional Family Member Program from providing gender transition services.
Received in the Senate.
The Senate has received the House-passed bill and will decide whether to take it up.
The Clerk was authorized to correct section numbers, punctuation, and cross references, and to make other necessary technical and conforming corrections in the engrossment of H.R. 3838.
Motion to reconsider laid on the table Agreed to without objection.
On passage Passed by recorded vote: 231 - 196 (Roll no. 262).
Passed/agreed to in House: On passage Passed by recorded vote: 231 - 196 (Roll no. 262).
The House of Representatives voted to approve this bill. It now goes to the Senate.
On Agreeing to the Amendment
An amendment numbered 1 printed in Part A of House Report 119-130 to require all HHS regulations or guidance documentation to use language that is inclusive of all opioid overdose reversal drugs that have been approved by FDA, instead of referring to brand names.
On Agreeing to the Amendment
Amendment is the reported version of the resolution, House Report 119-17 as reported by the Committee on House Administration.
On Agreeing to the Amendment
An amendment numbered 1 printed in House Report 119-38 to include any special administrative region or other territory within one of the covered nations referenced in the bill within the bill's definition of "foreign country of concern.".
Document Type
Congressional Bill
Official Title
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Analysis generated by AI. Always verify with official sources.